搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
oncnursingnews
2 天
QOL Considerations for Optimal Patient Outcomes with CAR-T Therapy
This video segment discusses strategies to help CAR-T therapy patients maintain quality of life, focusing on lifestyle ...
oncnursingnews
6 天
Telephone Follow-Ups May Reduce AEs in Locally Advanced ESCC
Phone calls to follow up with patients with locally advanced esophageal squamous cell carcinoma while at home may reduce AEs ...
oncnursingnews
2 天
Addressing Neurologic Toxicities in CAR-T Therapy: Monitoring, Management, and Patient ...
Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that ...
oncnursingnews
8 天
Bevacizumab’s Benefit in Colorectal Cancer May Be Limited to 2 Years Post-Administration
The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...
oncnursingnews
4 天
Recent and Upcoming Advances in Breast Cancer Treatment
Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...
oncnursingnews
2 天
Managing Neurotoxicities in CAR T: Clinical Approaches and Patient/Caregiver Education
This video segment explores the challenges of managing neurologic toxicities, including ICANS, in CAR-T therapy, highlighting ...
oncnursingnews
4 天
Balancing Treatment Benefits and Toxicity: Managing Quality of Life in EGFR+ NSCLC Patients
Key opinion leaders examine approaches to managing skin-related side effects, such as rash, in patients on EGFR inhibitors, ...
oncnursingnews
5 天
Managing Chemo-Induced Peripheral Neuropathy in Breast Cancer
BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...
oncnursingnews
6 天
FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer
T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈